By pooling all the studies, the p53 Arg72Pro polymorphism was not associated with a hematological malignancies risk, and this negative association maintained in some subgroup analyses such as ethnicities and sources of controls (Table 2). The gene discussed is TP53; the disease is hematologic disorder.